Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Moodys
UBS
Merck
Daiichi Sankyo
McKesson

Generated: April 22, 2019

DrugPatentWatch Database Preview

Polymyxin b sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for polymyxin b sulfate and what is the scope of polymyxin b sulfate freedom to operate?

Polymyxin b sulfate is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Mylan Asi, West-ward Pharms Int, X Gen Pharms, Xellia Pharms Aps, Paddock Llc, Allergan, Akorn Inc, Bausch And Lomb, and Sandoz Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for polymyxin b sulfate. Eight suppliers are listed for this compound.

Pharmacology for polymyxin b sulfate
Medical Subject Heading (MeSH) Categories for polymyxin b sulfate
Synonyms for polymyxin b sulfate
1405-20-5
1405-20-5, 4135-11-9 (free base)
405P205
AB2000085
AC1NWAPL
Aerosporin
Aerosporin, PMB, Poly-RX , 1405-20-5
Aerosporin;PMB;Poly-RX
AKOS015895662
AKOS025392172
AN-946
BCP12700
C55H96N16O13.2H2SO4
CCG-39724
CHEMBL1200626
FT-0654126
HFMDLUQUEXNBOP-OLYKAHIFSA-N
HFMDLUQUEXNBOP-UHFFFAOYSA-N
HMS1920J04
HMS2092A07
HMS502E14
I06-1086
I559
KS-1428
Listeria monocytogenes Selective Supplement I
M02428
MFCD00131991
MolPort-003-665-543
MolPort-035-783-496
NCGC00094763-01
NCGC00094763-02
NSC-757278
NSC757278
Pharmakon1600-01500492
Poly-RX
Polymixin B sulfate salt
Polymixin B sulphate
Polymixin B-sulfate
Polymyxin B Sulfate, Bacillus polymyxa
Polymyxin B sulphate
s1395
SC-19217
SPECTRUM1500492
SR-05000002074
SR-05000002074-1
SR-05000002074-2
sufuric acid

US Patents and Regulatory Information for polymyxin b sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 065006-001 Dec 17, 1998 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gland Pharma Ltd POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 207322-001 Apr 14, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 060716-001 Approved Prior to Jan 1, 1982 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Queensland Health
Fuji
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.